Evidence map›Paper›PMID 42806052›Full record

ArticleLeukemia2026

Clinical and molecular characteristics of clonal monocytosis with and without cytopenia(s).

Tariq Kewan, Hadil Zureigat, Pradeep Pankaj, Rong He, Dragan Jevremovic, Patricia Greipp, Antoine N Saliba, Aasiya Matin, Mehrdad Hefazi Torghabeh, Naseema Gangat and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Tariq KewanDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-4651-5125
Hadil ZureigatDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Pradeep PankajDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Rong HeDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-6116-8163
Dragan JevremovicDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-1792-5822
Patricia GreippDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5536-9011
Antoine N SalibaDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-5134-7336
Aasiya MatinDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Mehrdad Hefazi TorghabehDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-8860-3380
Naseema GangatDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.
William HoganDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5841-4105
Hassan AlkhateebDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-3609-8404
Cecilia Arana YiDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Arizona, USA.
James ForanDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Jacksonville, FL, USA.ORCID http://orcid.org/0000-0003-1673-1708
Mark LitzowDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-9816-6302
Mithun Vinod ShahDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-5359-336X
Kebede BegnaDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-2730-8593
Badar TalhaDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Jacksonville, FL, USA.ORCID http://orcid.org/0000-0003-1548-918X
Yael KusneDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Arizona, USA.
Abhishek A MangaonkarDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-2458-9887
Aref Al-KaliDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Kaaren ReichardDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Mrinal M PatnaikDepartment of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA. Patnaik.Mrinal@mayo.edu.ORCID http://orcid.org/0000-0001-6998-662X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clonal monocytosis of undetermined significance (CMUS) and clonal cytopenia with monocytosis of undetermined significance (CCMUS) are recently defined precursor states, with unclear progression rates to myeloid neoplasms (MN), including chronic myelomonocytic leukemia (CMML). We evaluated a cohort of 958 patients with sustained monocytosis ( ≥ 0.5 ×10

Identifiers

PMID42806052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.